Pioneering cancer survivorship care in Latin America: Early results from the OC sobre VIVER program in Brazil.
Abstract
1640 Background: Cancer survivorship poses a growing challenge, especially in low- and middle-income settings. The OC SobreVIVER program, launched in October, 2020 by the Oncoclínicas Group, addresses survivorship care gaps by providing structured, multidisciplinary care. Initially piloted for breast cancer survivors in two Brazilian units, the program expanded in 2023 to include colorectal and prostate cancer survivors across eight states. This study presents preliminary data. Methods: This descriptive, observational study assessed the OC SobreVIVER program’s impact on survivorship care. Multidisciplinary consultations involving oncologists, nurses, psychologists, and nutritionists addressed late toxicities, recurrence risk, and quality of life, following international survivorship guidelines. Telehealth and digital tools improved accessibility. Data from July, 2023 to December, 2024 included clinical characteristics, program metrics, and patient-reported satisfaction via EORTC PATSAT 33 and Net Promoter Score (NPS). Descriptive statistics summarized key outcomes. Results: From July 2023 to December 2024, the program supported 577 survivors (518 breast, 47 colorectal, 12 prostate) across 11 practices in eight states, with 490 initial consultations, 91 follow-ups, and over 20 support groups conducted.Virtual consultations were available to all patients, enhancing accessibility for underserved regions. Patient-reported satisfaction was high, with 95% of respondents classified as Promoters (scores 9–10) in the NPS, demonstrating strong program loyalty. Based on EORTC PATSAT 33 evaluations, over 80% of respondents rated their medical care experience in the highest satisfaction range (41–50), and over 80% rated their nursing care experience in the highest category (29–35). Minimal dissatisfaction was reported, with less than 2% of responses falling into the lowest satisfaction ranges (< 20 for medical care and < 14 for nursing care). Conclusions: The OC SobreVIVER program demonstrates the feasibility of a structured, multidisciplinary survivorship model in a private network across Brazil. Preliminary data highlight its effectiveness in addressing complex survivorship needs, enhancing accessibility through telehealth, and maintaining high satisfaction.This integrated, patient-centric approach ensures continuity of care across physical, social, psychological, spiritual, and nutritional dimensions, fostering a more comprehensive and holistic survivorship experience.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (17)
Luciana Landeiro
Oncoclínicas&Co, Salvador, Brazil
Thaiana Aragão Santana
Oncoclínicas&Co, Aracaju, Sergipe, Brazil
Mônica de Azevedo Kalile Kalile
Oncoclinicas&Co, Salvador, Brazil
Carla Pavei
Oncoclínicas&Co, Sao Paulo, Brazil
Elisa Mascarenhas
Oncoclínicas&Co, Brasila, Brazil
Maria Cecilia Borges Bittencourt
Oncoclínicas&Co, Sao Paulo, Brazil
Fernanda Oliveira
Department of Medicine, Federal University of Sao Paulo
Thais de Melo Passarini
Oncoclínicas&Co, Minas Gerais, Brazil
Denise Strassburger Nunes
Oncoclínicas&Co, Belo Horizonte, Brazil
Cristiane Decat Bergerot
Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil
Flavia Santos Dumont Sorice
Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil
Bruno Favato Neto
Oncoclínicas&Co, Sao Paulo, Brazil
Maria Helena Cruz Rangel Silva
Oncoclínicas&Co, Belo Horizonte, Brazil
Helaine Pantoja
Oncoclínicas&Co, Rio de Janeiro, Brazil
Carolina Perini
Oncoclínicas&Co, Curitiba, Brazil
Mariana Laloni
Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil
Rafael Brant Costa
Oncoclínicas&Co, Belo Horizonte, Brazil